Longevity Vision Fund logo

Longevity Vision Fund

North America, New York, United States, New York

Description

Longevity Vision Fund invests in technologies that have the potential to disrupt life sciences and extend healthy lifespan.

Investor Profile

Longevity Vision Fund has made 19 investments, with 0 in the past 12 months and 5% as lead.

Stage Focus

  • Series B (53%)
  • Series C (26%)
  • Series A (11%)
  • Convertible Note (5%)
  • Debt Financing (5%)

Country Focus

  • United States (84%)
  • Hong Kong (11%)
  • Isle of Man (5%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Medical Device
  • Life Science
  • Biopharma
  • Genetics
  • Therapeutics
  • Artificial Intelligence (Ai)
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Longevity Vision Fund frequently co-invest with?

Alaska Permanent Fund
North America, Alaska, United States, Juneau
Co-Investments: 2
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 2
Altitude Life Science Ventures
North America, Colorado, United States, Durango
Co-Investments: 2
SoftBank Vision Fund
Europe, England, United Kingdom, London
Co-Investments: 2
T. Rowe Price
North America, Maryland, United States, Baltimore
Co-Investments: 3
Artis Ventures (AV)
North America, California, United States, San Francisco
Co-Investments: 3
Mayo Clinic
North America, Minnesota, United States, Rochester
Co-Investments: 2
BlackRock
North America, New York, United States, New York
Co-Investments: 3
Bold Capital Partners
North America, California, United States, Santa Monica
Co-Investments: 3
Flagship Pioneering
North America, Massachusetts, United States, Cambridge
Co-Investments: 7

Which angels does Longevity Vision Fund often collaborate with?

KA
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Longevity Vision Fund?

Senda Biosciences

Cambridge, Massachusetts, United States

Senda Biosciences is a therapeutics platform company leveraging unprecedented insights into the molecular connections between humans.

BiotechnologyHealth CareLife Science
Series CAug 16, 2022
Amount Raised: $123,000,000
Tessera Therapeutics

Cambridge, Massachusetts, United States

Tessera Therapeutics is a biotechnology company that focuses on a new category of genetic medicines.

BiopharmaBiotechnologyGeneticsLife ScienceTherapeutics
Series CApr 19, 2022
Amount Raised: $300,000,000
Biolinq

San Diego, California, United States

Biolinq develops a wearable biosensor platform that is capable of measuring blood level information.

BiotechnologyHealth CareMedical DeviceWearables
Series BNov 2, 2021
Amount Raised: $100,000,000
Laronde

Cambridge, Massachusetts, United States

Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body.

BiotechnologyMedicalTherapeutics
Series BAug 30, 2021
Amount Raised: $440,000,000
Exo

Redwood City, California, United States

Exo is a medical device startup which develops handheld ultrasound devices and AI for imaging and therapeutic applications.

Health CareMedicalMedical Device
Series CJul 29, 2021
Amount Raised: $220,000,000
Senda Biosciences

Cambridge, Massachusetts, United States

Senda Biosciences is a therapeutics platform company leveraging unprecedented insights into the molecular connections between humans.

BiotechnologyHealth CareLife Science
Series BJun 10, 2021
Amount Raised: $98,000,000
Tessera Therapeutics

Cambridge, Massachusetts, United States

Tessera Therapeutics is a biotechnology company that focuses on a new category of genetic medicines.

BiopharmaBiotechnologyGeneticsLife ScienceTherapeutics
Series BJan 12, 2021
Amount Raised: $230,000,000
Valo Health

Boston, Massachusetts, United States

Valo Health is a technology company focused on utilizing large scale data and AI-driven computation to discover and develop therapeutics.

BiotechnologyHealth CareInformation TechnologyMedical
Series BJan 11, 2021
Amount Raised: $190,000,000
LyGenesis

Pittsburgh, Pennsylvania, United States

LyGenesis is an organ regeneration company that facilitates organ regeneration and transplant.

BiotechnologyClinical TrialsMedical
Convertible NoteDec 30, 2020
Amount Raised: $11,000,000
Eko Health

Emeryville, California, United States

Eko Health is a digital health company providing digital stethoscopes and an AI detection platform for diagnosing heart and lung diseases.

Artificial Intelligence (AI)Health CareHealth DiagnosticsMachine LearningMedical DevicemHealthSoftware
Series CNov 9, 2020
Amount Raised: $65,000,000